| Real-time Estimate Cboe BZX - 10:52:16 2023-08-01 am EDT |
|
5-day change | 1st Jan Change | |
| 135.61 USD | +0.29% | -6.63% | -13.51% | |
| Jul. 31 | Quest Diagnostics launches Alzheimer's blood test for consumers | RE |
| Jul. 31 | Quest Diagnostics Launches AD-Detect Test for Alzheimer's Disease | MT |
Financials (USD)
| Sales 2023 * | 9,184 M | Sales 2024 * | 9,339 M | Capitalization | 15 175 M |
|---|---|---|---|---|---|
| Net income 2023 * | 912 M | Net income 2024 * | 961 M | EV / Sales 2023 * | 2,08x |
| Net Debt 2023 * | 3,890 M | Net Debt 2024 * | 3,459 M | EV / Sales 2024 * | 2,00x |
| P/E ratio 2023 * | 17,2x | P/E ratio 2024 * | 16,1x | Employees | 44,500 |
| Yield 2023 * | 2,02% | Yield 2024 * | 2,11% | Free-Float | 68.60% |
More Fundamentals
* Assessed data
Chart Quest Diagnostics Incorporated
Latest news about Quest Diagnostics Incorporated
More news
Analyst Recommendations on Quest Diagnostics Incorporated
More news
Press releases Quest Diagnostics Incorporated
More press releases
News in other languages on Quest Diagnostics Incorporated
More news
Quotes and Performance
| 1 day | +0.24% | ||
| 1 week | -6.63% | ||
| Current month | +0.07% | ||
| 1 month | -2.76% | ||
| 3 months | -2.99% | ||
| 6 months | -8.97% | ||
| Current year | -13.51% |
Highs and lows
1 week
132.70
141.24
1 month
132.70145.58
Current year
129.55157.36
1 year
120.40158.34
3 years
104.10174.16
5 years
73.02174.16
10 years
50.46174.16
Insiders
| Managers | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 60 | 2022 |
Sam Samad
DFI | Director of Finance/CFO | 53 | 2022 |
| Compliance Officer | 61 | 1999 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tim Ring
BRD | Director/Board Member | 66 | 2011 |
James Davis
CHM | Chairman | 60 | Mar. 31 |
Gail Wilensky
BRD | Director/Board Member | 79 | 1996 |
ETFs positioned on Quest Diagnostics Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.84% | 252 | -15.89% | - | |
| 6.13% | 21 | +0.52% | - | |
| 3.84% | 249 | +9.03% | - | |
| 3.80% | 16 | -8.64% |
Quotes 5-day view
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-08-01 | 135.31 | +0.29% | 204 137 |
| 23-07-31 | 135.21 | +0.54% | 960,841 |
| 23-07-28 | 134.49 | +0.10% | 686,996 |
| 23-07-27 | 134.36 | -1.38% | 1,067,037 |
| 23-07-26 | 136.24 | -5.99% | 2,181,419 |
Delayed Quote Nyse - 10:37:15 2023-08-01 am EDT
More quotesCompany Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
2023-10-18
- Q3 2023 Earnings Release (Projected)
Income Statement Evolution
Ratings for Quest Diagnostics Incorporated
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
135.21USD
Average target price
147.26USD
Spread / Average Target
+8.91%
EPS Revisions
Quarterly earnings - Rate of surprise
Sector Other Healthcare Facilities & Services
| 1st Jan change | Capi. (M$) | |
|---|---|---|
| -13.51% | 15 175 M $ | |
| +54.89% | 15 269 M $ | |
| +19.91% | 17 092 M $ | |
| -10.03% | 18 976 M $ | |
| -1.73% | 9 755 M $ | |
| +36.73% | 9 246 M $ | |
| +2.18% | 7 823 M $ | |
| +53.99% | 7 618 M $ | |
| -4.23% | 7 284 M $ | |
| +53.61% | 7 227 M $ |